Biomarker Driven Treatment of Selected NSCLC: EGFR, EGFR TKI in Mutant EGFR NSCLC, Mechanisms of Resistance and New Generation EGFR TKI

Date 19 January 2018
Event ESMO Preceptorship on NSCLC Singapore November 2017
Session Session 4 Biomarker Driven Treatment
Topics Lung and other Thoracic Tumours
Presenter J. Bennouna, FR